Abscopal Effect of Radiotherapy and Nivolumab in Relapsed or Refractory Hodgkin Lymphoma (AERN): An International Multicenter Single-Arm Two-Stage Phase II GHSG Trial

被引：4

作者：

Broeckelmann, Paul J. ^{[1
,2
]}

Pluetschow, Annette ^{[1
,2
]}

Greil, Richard ^{[3
,4
,5
]}

Zijlstra, Josee M. ^{[6
]}

Illidge, Timothy ^{[7
]}

Fossa, Alexander ^{[8
,9
]}

Meissner, Julia ^{[10
,11
]}

Zimmermann, Andreas ^{[12
]}

Mathas, Stephan ^{[13
]}

Thol, Felicitas ^{[14
]}

Fuchs, Michael ^{[1
,2
]}

Engert, Andreas ^{[1
,2
]}

Baues, Christian ^{[15
,16
]}

机构：

[1] Univ Cologne, German Hodgkin Study Grp, Cologne, Germany

[2] Univ Cologne, Dept Internal Med 1, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Cologne, Germany

[3] Paracelsus Med Univ, Med Dept Hematol 3, Med Oncol Rheumatol & Infectiol, Salzburg, Austria

[4] Salzburg Canc Res Inst, Ctr Clin Canc & Immunol Trials, Salzburg, Austria

[5] Canc Cluster Salzburg, Salzburg, Austria

[6] Vrije Univ Amsterdam, Dept Hematol, Amsterdam UMC, Canc Ctr Amsterdam, Amsterdam, Netherlands

[7] Univ Manchester, Manchester Acad Hlth Sci, Natl Inst Hlth & Res,Biomed Res Ctr,Fac Biol Med, Christie Hosp Natl Hlth Serv Fdn Trust,Div Canc S, Manchester, Lancs, England

[8] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway

[9] Oslo Univ Hosp, Oslo, Norway

[10] Heidelberg Univ, Med 5, Heidelberg, Germany

[11] Univ Heidelberg Hosp, Dept Internal Med 5, Heidelberg, Germany

[12] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Hematol Oncol, Munich, Germany

[13] Charite Univ Med Berlin, Hematol Oncol & Tumor Immunol, Berlin, Germany

[14] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, NH, Germany

[15] Univ Hosp Cologne, Fac Med, Dept Radiooncol & Cyberknife Ctr, Cologne, Germany

[16] Univ Hosp Cologne, Cologne, Germany

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124351

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1547

引用

页数：4

共 50 条

[41] Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre single-arm, phase 2 trial
Alderuccio, Juan Pablo
Alencar, Alvaro J.
Schatz, Jonathan H.
Kuker, Russ A.
Pongas, Georgios
Reis, Isildinha M.
Lekakis, Lazaros J.
Spiegel, Jay Y.
Sandoval-Sus, Jose
Beitinjaneh, Amer
Stanchina, Michele D.
Trabolsi, Asaad
Lossos, Izidore S.
Rosenblatt, Joseph D.
Lessen, David S.
Moskowitz, Craig H.
LANCET HAEMATOLOGY, 2025, 12 (01): : e23 - e34
[42] Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial
Zander, Thilo
Pabst, Thomas
Schaer, Saemi
Aebi, Stefan
Mey, Ulrich
Novak, Urban
Lerch, Erika
Agocs, Gaelle Rhyner
Goede, Jeroen
Maniecka, Zuzanna
Hayoz, Stefanie
Ruefer, Axel
Renner, Christoph
Driessen, Christoph
LEUKEMIA, 2023, 37 (03) : 699 - 701
[43] Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial
Thilo Zander
Thomas Pabst
Sämi Schär
Stefan Aebi
Ulrich Mey
Urban Novak
Erika Lerch
Gaëlle Rhyner Agocs
Jeroen Goede
Zuzanna Maniecka
Stefanie Hayoz
Axel Rüfer
Christoph Renner
Christoph Driessen
Leukemia, 2023, 37 : 699 - 701
[44] ELARA: A phase II, single-arm, multicenter, open label trial investigating the efficacy and safety of tisagenlecleucel in adult patients with refractory/relapsed follicular lymphoma (r/r FL).
Dickinson, Michael
Popplewell, Leslie
Kolstad, Arne
Ho, Joy
Teshima, Takanori
Dreyling, Martin H.
Schuster, Stephen J.
Thieblemont, Catherine
Yateman, Nigel
Lehnhoff, Katja
Lawniczek, Tomasz
Bubuteishvili-Pacaud, Lida
Fowler, Nathan Hale
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[45] Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Ansell, Stephen M.
Minnema, Monique C.
Johnson, Peter
Timmerman, John M.
Armand, Philippe
Shipp, Margaret A.
Rodig, Scott J.
Ligon, Azra H.
Roemer, Margaretha G. M.
Reddy, Nishitha
Cohen, Jonathon B.
Assouline, Sarit
Poon, Michelle
Sharma, Manish
Kato, Kazunobu
Samakoglu, Selda
Sumbul, Anne
Grigg, Andrew
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (06) : 481 - +
[46] Low-Dose Radiation Therapy with Nivolumab in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of the Phase II Radvax Trial
LaRiviere, Michael J.
Vaziri, Tina
Farwell, Michael
Maity, Amit
Paydar, Ima
Schuster, Stephen J.
Nasta, Sunita Dwivedy
Chong, Elise A.
Landsburg, Daniel J.
Plastaras, John P.
Svoboda, Jakub
BLOOD, 2022, 140 : 3726 - 3727
[47] Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
Morschhauser, Franck
Tilly, Herve
Chaidos, Aristeidis
McKay, Pamela
Phillips, Tycel
Assouline, Sarit
Batievi, Connie Lee
Campbell, Phillip
Ribrag, Vincent
Damaj, Gandhi Laurent
Dickinson, Michael
Jurczak, Wojciech
Kazmierczak, Maciej
Opat, Stephen
Radford, John
Schmitt, Anna
Yang, Jay
Whalen, Jennifer
Agarwal, Shefali
Adib, Deyaa
Salles, Gilles
LANCET ONCOLOGY, 2020, 21 (11): : 1433 - 1442
[48] Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial
Broeckelmann, Paul J.
Buehnen, Ina
Meissner, Julia
Trautmann-Grill, Karolin
Herhaus, Peter
Halbsguth, Teresa, V
Schaub, Valdete
Kerkhoff, Andrea
Mathas, Stephan
Bormann, Matthias
Dickhut, Andreas
Kaul, Helen
Fuchs, Michael
Kobe, Carsten
Baues, Christian
Borchmann, Peter
Engert, Andreas
von Tresckow, Bastian
BLOOD, 2022, 140 : 1753 - 1755
[49] Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial (vol 19, pg 257, 2018)
O'Connor, O. A.
Lue, J. K.
Sawas, A.
LANCET ONCOLOGY, 2018, 19 (03): : E137 - E137
[50] Linperlisib in Conjunction with Gemcitabine and Oxaliplatin in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Single-Arm Phase Ib/II Study
Li, Zhiming
Sun, Peng
Cen, Hong
Yang, Haiyan
Huang, Rui
Cai, Zhen
Gu, Xuekui
BLOOD, 2023, 142

← 1 2 3 4 5 →